• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LIN Jin, WANG Xu, WANG Jian, XU Xiuzhi, CHEN Yaohao, LI Zhulai. Synthesis and antitumor activities of 4-(N-aryl)amino-6-long chain alkoxy pteridine derivatives[J]. Journal of China Pharmaceutical University, 2018, 49(1): 64-71. DOI: 10.11665/j.issn.1000-5048.20180109
Citation: LIN Jin, WANG Xu, WANG Jian, XU Xiuzhi, CHEN Yaohao, LI Zhulai. Synthesis and antitumor activities of 4-(N-aryl)amino-6-long chain alkoxy pteridine derivatives[J]. Journal of China Pharmaceutical University, 2018, 49(1): 64-71. DOI: 10.11665/j.issn.1000-5048.20180109
shu

Synthesis and antitumor activities of 4-(N-aryl)amino-6-long chain alkoxy pteridine derivatives

More Information
    Graphical Abstract
    • Abstract
  • A series of 4-(N-aryl)amino-6-alkoxyl pteridine derivatives was designed and synthesized via the bioisostere principle using anti-cancer drugs with quinazoline cores as lead compounds. The proliferative inhibitory activities of the synthesized compounds against tumor cells A549, KG1a and HGC-27 were also performed by MTT assay. Using methyl 3-aminopyrazine-2-carboxylate as the starting material, 12 target compounds( 7a - 7l )were synthesized through six-step reaction, and characterized by 1H NMR, 13C NMR and MS. It was showed that antitumor activity of pteridines with 2-chloro-5-nitro-anilino substituted in position 4 was more potent than that of others. The activity of compound 7b on A549 cells(IC50=11. 55 μmol/L)was closely approximate to that of positive control gefitinib(IC50=5. 95 μmol/L). IC50 values of compound 7k on three cell lines were all close to those of gefitinib. A 2-chloro-5-nitro-anilino fragment was contained in preferred compounds which might be modified for further investigation.
    • FullText(HTML)
    • References (14)
  • [1]
    Gschwind A,Fischer OM,Ullrich A.The discovery of receptor tyrosine kinases targets for cancer therapy[J].Nat Rev Cancer,2004,4(5):361-370.
    [2]
    Chahrour O,Cairns D,Omran Z.Small moleculekinase inhibitors as anti-cancer therapeutics[J].Mini Rev Med Chem,2012,12(5):399-411.
    [3]
    Zhou W,Liu X,Tu Z,et al.Discovery of pteridin-7(8H)-onebased irreversible inhibitors targeting the epidermal growth factor receptor(EGFR)kinase T790M/L858R mutant[J].J Med Chem,2013,56(20):7821-7837.
    [4]
    Sun D,Yang Y,Lyu J,et al.Discovery and rational design of pteridin-7(8H)-one-based inhibitors targeting FMS-like tyrosine kinase 3(FLT3)and its mutants[J].J Med Chem,2016,59(13):6187-6200.
    [5]
    Ellingson RC,Henry R,McDonald FG,et al.Derivatives 3-aminopyrazinoic acid[J].J Am Chem Soc,1945,67(10):1711-1713.
    [6]
    Albert A,Ohta K,Studies P,et al.New routes to 4-aminopteridines via 3-(dimethylaminomethyleneamino)pyrazine-2-carbonitrile and related compounds[J].J Chem Soc,1971,22:3727-3730.
    [7]
    Li MD.Design,Synthesis and structure-activity-relation study of novel anti-cancer compounds targeted on protein tyrosine kinase(作用于酪氨酸激酶的抗肿瘤小分子抑制剂的设计与合成)[D].Nanjing:Southeast University,2007.
    [8]
    Duan C,Jia J,Zhu R,Wang J.Synthesis of N-substituted-6-alkoxypteridin-4-amine[J].J Het Chem,2012,49(4):865-872.
    [9]
    Traxler P, Furet P. Strategies toward the design of novel and selective protein tyrosine kinase inhibitors[J].Pharmacol Ther,1999,82(2/3):195-206.
    [10]
    Lawrence DS,Niu J.Protein kinase inhibitors:the tyrosine-specific protein kinases[J].Pharmacol Ther,1998,77(2):81-114.
    [11]
    Stamos J,Sliwlowski MX,Eigenbrot C.Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor[J].J Biol Chem,2002,277(48):46265-46272.
    [12]
    Sun J,Li D,Li J,et al.Design,synthesis,biological evaluation,and molecular modeling study of 4-alkoxyquinazoline derivatives as potential VEGFR2 kinase inhibitors[J].Org Biomol Chem,2013,11(44):7676-7686.
    [13]
    Qin X,Li Z,Yang L,et al.Discovery of new[1,4] dioxino[2,3-f]quinazoline-based inhibitors of EGFR including the T790M/L858R mutant[J].Bioorg Med Chem,2016,24(13):2871-2881.
    [14]
    Debnath AK,Hansch C.Structure-activity relationship of genotoxic polycyclic aromatic nitro compounds:further evidence for the importance of hydrophobicity and molecular orbital energies in genetic toxicity[J].Environ Mol Mutagen,1992,20(2):140-144.
    • Related Articles

  • Related Articles

    [1]ZHAO Xiaomei, WANG Xin, JI Xia, Zhang Jing, ZHANG Hua, HU Guoqiang. Synthesis and antitumor activity of heteroatom-substituted azulenes derivatives of 1,2-benzothiazine[J]. Journal of China Pharmaceutical University, 2024, 55(5): 634-638. DOI: 10.11665/j.issn.1000-5048.2023120503
    [2]SUN Dongyu, GONG Jingxu, LI Xuwen, HAN Guanying, GUO Yuewei. Studies on methyl xestopongoate analogues:design, synthesis and antitumor activities[J]. Journal of China Pharmaceutical University, 2018, 49(4): 413-421. DOI: 10.11665/j.issn.1000-5048.20180405
    [3]LI Mingtao, XU Dan, XUE Wenjun, YOU Qidong, SUN Liping. Design, synthesis and antitumor activities of oxazolo［5, 4-d］pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(4): 425-431. DOI: 10.11665/j.issn.1000-5048.20170406
    [4]QIAO Yixue, MOU Yi, HUANG Zhangjian, AI Yong, KANG Fenghua, LAI Yisheng, ZHANG Yihua. Synthesis and antitumor activities of novel CDDO-Me analogues[J]. Journal of China Pharmaceutical University, 2015, 46(3): 289-293. DOI: 10.11665/j.issn.1000-5048.20150305
    [5]MAO Chunfang, XU Chenjun, WANG Xuemin, LI Xianghua, ZHANG Wei, WANG Xinyang, LING Yong. Design, synthesis and antitumor activity of farnesylthiosalicylamide derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(2): 162-168. DOI: 10.11665/j.issn.1000-5048.20150204
    [6]HU Kun, ZHOU Anfei, JIANG Hefei, XU Yuanyuan, HUANG Qianhui, YANG Jie, CHEN Xin, REN Jie. Synthesis and antitumor activities of podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 33-38. DOI: 10.11665/j.issn.1000-5048.20140105
    [7]CHENG Keguang, CHU Xiangwu, LIU Guanyan, SU Chunhua, DENG Shengping, PAN Hongmei. Synthesis and antitumor activities of 3-substituted estradiol-pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 26-32. DOI: 10.11665/j.issn.1000-5048.20140104
    [8]LIU Dexiu, PAN Huaying, SHI Hui, HUANG Xiaoying, LOU Hongxiang. Synthesis and antitumor activity of a novel bisbibenzyl derivative[J]. Journal of China Pharmaceutical University, 2013, 44(6): 515-519. DOI: 10.11665/j.issn.1000-5048.20130605
    [9]HU Kun, XU Hua-jin, XIN Wen-qun, CHEN Xin, REN Jie. Synthesis and antitumor activity of nitrogen mustard derivatives of formononetin[J]. Journal of China Pharmaceutical University, 2012, 43(2): 113-119.
    [10]ZHA Xiao-ming, ZHANG Fei-ran, SHAN Jia-qi, CHEN Yan-ke, ZHANG Yi-hua, LIU Jun, SUN Hong-bin. Synthesis and in vitro antitumor activities of novel soladulcidine derivatives[J]. Journal of China Pharmaceutical University, 2010, 41(6): 493-498.

Catalog

    Get Citation
    PDF
    XML
    Article views (887) PDF downloads (1093) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：366189

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return